Efficacy Evaluation and Mechanism Study of Ketogenic Diet on Autism Spectrum Disorder in Children
NCT ID: NCT06348433
Last Updated: 2024-10-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2024-03-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketogenic Diet Therapy for Autism Spectrum Disorder
NCT02477904
Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
NCT03434366
Efficacy of MAD as add-on Therapy in Comparison With Standard of Care in Children With ASD
NCT06315465
Effects of Virtual Discrete Trial Training on Children With Autism Spectrum Disorder
NCT06522490
Efficacy of Nutritional Supplements on Children With Autism Spectrum Disorder
NCT06911905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
First of all, ASD children who come from the outpatient department of pediatric care, Qilu Hospital, Shandong University and have the willingness to join the group are evaluated, and the three routine auxiliary examinations are improved, such as liver and kidney function, blood lipid, myocardial enzyme, hematuria screening for genetic metabolic diseases, EEG and other ketogenic diet-related examinations. ASD children who meet the entry conditions sign informed consent and complete Gastrointestinal Symptom Rating Scale (GSRS score), Children's Sleep Habit Questionnaire (CSHQ) and Spectral Magnetic Resonance(MRS). Children in ketogenic diet group are randomly divided into ketogenic diet group or ordinary diet group by doctors Children in the ordinary diet group can still eat according to the previous diet structure and mode, and are followed up by doctors throughout the whole process.
During this period, children in ketogenic diet group should regularly check blood glucose and ketone values, and measure their height and weight. The outpatient follow-up time is the 30th and 90th days of participating in this project.
2. The subjects were treated with ketogenic diet. Ketogenic diet is a formula diet with high fat, low carbohydrate, proper amount of protein and other nutrients. In 1921, Wilder, an American doctor, first put forward the concept of "ketogenic diet", which was used to treat epilepsy in children and achieved remarkable results. After 100 years' development, ketogenic diet has evolved into a variety of diet schemes, among which four are recognized by scholars at home and abroad, namely classic ketogenic diet (classic KD), medium chain triglyceride diet (MCT diet), improved Atkins diet (improved MAD) and low glycemic index therapy (LGIT).We chose the classic ketogenic diet as the treatment plan.Its keto food (fat) g/non-keto food (protein and carbohydrate) g ratio is 4: 1, fat accounts for about 90%, protein is about 7%, and carbohydrates are about 3%, limiting calorie intake. Professional nutritionists will refer to the height and weight percentile value table of children and adolescents aged 0-18 to evaluate the growth and development of children. If the growth and development are within the standard range or low, the recommended hot card is the actual weight \* Recommended per kilogram The intake of hot cards should be high. If the growth and development are higher than the standard range, the recommended hot cards should be the standard weight corresponding to the actual height \* Recommend the intake of hot cards per kilogram, and combine the amount of exercise of the child and whether to take hormone drugs, etc. An individualized diet plan for its growth and development, after determining the hot card, the nutritionist will carry out individualized meals according to the child's food allergies and other conditions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketogenic diet group
The subjects were treated with ketogenic diet. Ketogenic diet is a formula diet with high fat, low carbohydrate, proper amount of protein and other nutrients.ASD behavioral intervention measures are designed to help ASD patients improve their social communication skills, communication skills, behavior and other difficulties. Common intervention methods of ASD behavior include cognitive behavioral therapy, social skills training and so on.
Ketogenic diet
Ketogenic diet is a formula diet with high fat, low carbohydrate, proper amount of protein and other nutrients.
Ordinary diet group
ASD behavioral intervention measures are designed to help ASD patients improve their social communication skills, communication skills, behavior and other difficulties. Common intervention methods of ASD behavior include cognitive behavioral therapy, social skills training and so on.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketogenic diet
Ketogenic diet is a formula diet with high fat, low carbohydrate, proper amount of protein and other nutrients.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sign informed consent/agree to use ketogenic diet.
Exclusion Criteria
* Children who fail to maintain proper nutrition or fail to cooperate;;
* There are obvious intracranial lesions, organic brain diseases, abnormal liver function, abnormal kidney function and cardiovascular diseases;
* There are metal implants or metal foreign bodies in the body.
18 Months
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qilu Hospital of Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yu Wang
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QL000003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.